KCNMA1 and rheumatoid arthritis: Importantly, FLS do not express Kv1.3, and the Kv1.3 blocker ShK-186 does not inhibit the RA-FLS pathogenic phenotype, because ShK-186 does not block KCa1.1 channels [19, 31, 32].